120 related articles for article (PubMed ID: 11321147)
1. Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy.
Shaikh S; Blumenkranz MS
Retina; 2001; 21(2):176-8. PubMed ID: 11321147
[No Abstract] [Full Text] [Related]
2. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
3. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Degenring RF; Kamppeter B; Kreissig I; Jonas JB
Acta Ophthalmol Scand; 2003 Aug; 81(4):399-401. PubMed ID: 12859269
[No Abstract] [Full Text] [Related]
4. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
Udaondo P; Garcia-Delpech S; Salom D; Garcia-Pous M; Díaz-Llopis M
Am J Ophthalmol; 2011 Aug; 152(2):326-7; author reply 327-8. PubMed ID: 21784203
[No Abstract] [Full Text] [Related]
7. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Degenring RF; Kamppeter B; Kreissig I; Jonas JB
Acta Ophthalmol Scand; 2003 Oct; 81(5):548-50. PubMed ID: 14510813
[No Abstract] [Full Text] [Related]
8. Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment.
Lockington D; Imrie F; Gillen J; Fitzpatrick A; Willison H
Can J Ophthalmol; 2010 Dec; 45(6):649. PubMed ID: 20935688
[No Abstract] [Full Text] [Related]
9. DEXAMETHASONE IMPLANT FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION IN PATIENTS YOUNGER THAN 50 YEARS.
Battaglia Parodi M; Iacono P; Sacconi R; Parravano M; Varano M; Bandello F
Retina; 2015 Jul; 35(7):1381-6. PubMed ID: 26102437
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
Sakuma T; Mizota A; Inoue J; Tanaka M
Am J Ophthalmol; 2010 Dec; 150(6):876-82. PubMed ID: 20801424
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
Ehlers JP; Decroos FC; Fekrat S
Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
[TBL] [Abstract][Full Text] [Related]
12. [Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions].
Niederhauser N; Valmaggia C
Klin Monbl Augenheilkd; 2013 Apr; 230(4):405-8. PubMed ID: 23629792
[TBL] [Abstract][Full Text] [Related]
13. Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice.
Matonti F; Meyer F; Guigou S; Barthelemy T; Dumas S; Gobert F; Hajjar C; Merite PY; Parrat E; Rouhette H; Pommier S
Acta Ophthalmol; 2013 Nov; 91(7):e584-6. PubMed ID: 23764276
[No Abstract] [Full Text] [Related]
14. The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema.
Kola M; Hacioglu D; Turk A; Erdol H
Cutan Ocul Toxicol; 2016 Sep; 35(3):185-9. PubMed ID: 26340259
[TBL] [Abstract][Full Text] [Related]
15. [Ozurdex, modern therapy for macular edema in central retinal vein occlusion].
Blajan C; Nicula D
Oftalmologia; 2012; 56(3):40-5. PubMed ID: 23713337
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
17. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
19. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.
Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM
Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824
[TBL] [Abstract][Full Text] [Related]
20. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
Ozkok A; Saleh OA; Sigford DK; Heroman JW; Schaal S
Retina; 2015 Jul; 35(7):1393-400. PubMed ID: 25748280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
